PharmaSource Podcast
oleh Life Science Networks
Episode terbaru
Manufacturing Network Strategy: “You Can’t Have Your Cake and Eat…
Manufacturing Network Strategy: “You Can’t Have Your Cake and Eat…
Tentang podcast ini
Welcome to the PharmaSource podcast: the pharma and biotech podcast that explores the latest trends, challenges, and commercial opportunities shaping the biopharma manufacturing and outsourcing.
In each episode we'll be speaking with top executives, researchers, and outsourcing experts, who share their perspectives on topics such as building a smarter, more sustainable supply chain, how to partner with CDMOs, digital transformation, procurement and external manufacturing strategies, and plenty more besides.
Make sure to subscribe for your regular dose of pharma insight.
Episode
20 episode terbaru dari 280
- Manufacturing Network Strategy: “You Can’t Have Your Cake and Eat It”: Pfizer, Biogen, Astellas and ROIS · 36 mntPolicy shifts, tariff threats and a wave of U.S. investment announcements have left outsourcing leaders asking the same question: do you consolidate to fewer, deeper CDMO…
- CDMO Live Americas State of the Industry: Five Takeaways on Tariffs, Reshoring, China and Talent from CDMO Live Americas 2026 · 32 mntRecorded live from CDMO Live Americas 2026. Marta Wosińska senior fellow at The Brookings Institution, Reza Oliyai, president and CEO of Oliyai Consulting, and Kenneth Drew, vice…
- Pharma Supply Chain Sustainability: How Sanofi, Sharp Services and My Green Lab Are Moving From Commitment to Execution · 55 mnt“If our suppliers fail, we’ll fail, and if they succeed, we’ll succeed.” That’s how José Francisco Vallejo Cabrera of Sanofi describes big pharma’s relationship with its…
- How Axplora Uses Strategic CDMO Partnerships to Take 6-9 Months Off ADC Payload Timelines · 27 mnt“You have to have something to work on together. You have to have something that you both are invested in. In this case, moving the molecule forward,” says Martin Meeson, CEO of…
- How Piramal Built Patient Centricity Into 15 Global CDMO Sites · 17 mnt“To us, it’s exactly the opposite of a marketing slogan. If we make a decision that has a negative impact on a patient, we’ve made a bad decision,” says Stuart Needleman. Stuart…
- 7 Lessons on Pharma Data Quality and Digital Transformation from Sakara Digital's Amie Harpe · 38 mnt“If the data you give it is weak, the model becomes a liability rather than an asset. In regulated industries, that’s not just a technical failure; it’s potentially a compliance…
- Three Packaging Bottlenecks Slowing GLP-1 Scale-Up · 21 mntAt CDMO Live Europe 2026, Alexander Schäfer, Business Development Manager at Sharp, laid out the scale of the GLP-1 packaging challenge and identified the three collaboration…
- Container Closure Integrity: 6 Considerations for Evaluating CDMO Capabilities · 28 mntContainer closure integrity (CCI) is a critical element of sterile product quality, but evaluating a CDMO’s CCI capabilities requires more than confirming that testing is…
- How to Select and Sustain an Early-Stage CDMO Partnership · 36 mntAt CDMO Live Europe 2026, Giulio Cavalli, Principal Lead External Manufacturing, J&J Innovative Medicine; Neil Stevenson, Director, CMC Logic Consultancy; Marine Joly Battaglini…
- What Changes When Pharma Outsources Outcomes, Not Just People? · 37 mnt“Traditional staff augmentation says, ‘Here are the people you asked for.’ An outcome-led model says, ‘Here is the service or capability you asked for, and we are accountable and…
- Europe Needs to Pick a Side: Why Geopolitics Is Forcing a Rethink of Pharma Supply Network Design · 37 mntSponsored by Blue Jet Healthcare, this panel at CDMO Live Europe 2026 brought together Bernhard Boehm, Head of External Manufacturing Animal Health, Boehringer Ingelheim; Philip…
- AI in Biopharma Manufacturing: Why Build-or-Buy Is the Wrong First Question · 30 mnt“AI is marketed as such an approachable, ubiquitous thing that everybody thinks they can vibe code it. Unfortunately, a lot of companies are starting to think that way,” says Kat…
- What CDMOs Get Wrong About AI for Bioprocessing, According to Sapiens Health’s Seungik Cho · 37 mnt“How good is your AI model? That’s the wrong question. The right question is: what does your AI model actually help your company do?” Seungik Cho, founder of Sapiens Health, has…
- How to Identify a Root Cause Without Delay: Interlabor's Troubleshooting Framework · 23 mntAt CDMO Live Europe 2026, Dr. Olivier Aebischer, Deputy CEO at Interlabor Belp AG, demonstrated how a structured, dual-path analytical approach can identify manufacturing root…
- How ExoZymes Is Running a 10-CDMO RFP for CDMO Selection · 19 mnt“We can adjust and be flexible around equipment configuration, but we can’t be flexible around what is a clear communicator and an honest partner.” Damien Perriman is Chief…
- How EU Sustainability Regulations Are Reshaping CDMO Manufacturing · 33 mnt“Rather than saying that there’s a gap from the industry, I think there’s a listening gap from our governments.” Neha Dave is an independent EU Government Affairs Advisor based…
- "Stop Talking About Resilience in the Future Tense": What Pharma Actually Wants From CDMOs · 26 mntModerated by Raman Sehgal, Host of Molecule to Market, this opening panel at CDMO Live Europe 2026 brought together Melanie Wamsler, External Network Strategy Lead, Takeda, Rocco…
- Abzena on AOCs: Building US Capacity to Compete With China · 38 mnt“There isn’t enough capacity for antibody-oligo conjugates out there today, full stop,” says Geoff Glass, CEO of Abzena. “And it’s really because of the volume requirements for…
- “Mexico Is the New China”: Reshoring Institute Executive Director Rosemary Coates on the Future of Pharmaceutical Reshoring · 35 mnt“If you look at the employment numbers in the manufacturing sector, it’s been absolutely flat for two years. The political noise has not driven that big wave of reshoring that we…
- How Cognition Therapeutics Cut Cost of Goods by 85% Through Smarter CMC Strategy · 29 mnt“No one is going to care about your project as much as you do.” Steven Weissman is Vice President and Head of CMC at Cognition Therapeutics, a small pharma company outside New…
